Martin Capital Partners LLC Buys 3,555 Shares of The Clorox Company $CLX

Key Points

• Martin Capital Partners LLC significantly increased its stake in The Clorox Company by 172.6% during the second quarter, owning 5,615 shares worth approximately $674,000.
• Clorox's recent earnings report showed better-than-expected results, with an EPS of $2.87 compared to analysts' expectations of $2.24, along with a revenue of $1.99 billion.
• The company recently declared a quarterly dividend of $1.24 per share, representing an annual dividend yield of 4.0%, which is an increase from the previous quarterly dividend.

Martin Capital Partners LLC increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 172.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,615 shares of the company's stock after buying an additional 3,555 shares during the quarter. Martin Capital Partners LLC's holdings in Clorox were worth $674,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after purchasing an additional 65,924 shares in the last quarter. Northern Trust Corp boosted its stake in Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock worth $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Invesco Ltd. boosted its stake in Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock worth $200,512,000 after purchasing an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Clorox by 3.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company's stock worth $170,406,000 after purchasing an additional 41,485 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Clorox by 12.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock worth $181,213,000 after purchasing an additional 123,200 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Down 0.8%

Shares of CLX stock traded down $0.96 on Friday, hitting $123.16. 936,668 shares of the stock were exchanged, compared to its average volume of 1,660,877. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a market capitalization of $15.06 billion, a P/E ratio of 18.88, a price-to-earnings-growth ratio of 1.01 and a beta of 0.52. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37. The business has a 50-day moving average of $124.14 and a 200 day moving average of $131.59.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. During the same quarter in the previous year, the business posted $1.82 EPS. The business's quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox's dividend payout ratio is 76.07%.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. JPMorgan Chase & Co. boosted their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Morgan Stanley reduced their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Barclays lowered their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Reduce" and an average target price of $142.18.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.